Sensitive outcome measures are urgently needed for trials of disease-modifying therapies for degenerative ataxias. In this Consensus Statement, the Ataxia Global Initiative MRI Biomarkers Working ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results